CTT PHARMACEUTICAL HOLDINGS, INC.
CEO, Director
CompanyBuying only
- 2024
- Oct 6, 2026
- 27
Other insiders active in the same sector
No other insider has filed at CTT PHARMACEUTICAL HOLDINGS, INC.'s companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $63.45M in SEPN purchases and sales in the last 12 months
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- Mario Schlosser - $62.90M in OSCR purchases and sales in the last 12 months
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is CTT PHARMACEUTICAL HOLDINGS, INC.?
CTT PHARMACEUTICAL HOLDINGS, INC. is a corporate entity, tracked as CEO, Director of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH). InsiderAlpha holds 27 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has CTT PHARMACEUTICAL HOLDINGS, INC. submitted recently?
14 primary Form 4 filings in the last 90 days, covering 1 company.
Has CTT PHARMACEUTICAL HOLDINGS, INC. been buying or selling stock?
Recorded transactions: 27 open-market purchases ($28K) and 0 open-market sales across all tracked filings.
